Clinical Trial Update: Safety and Efficacy of Arterial Delivery of Autologous Bone Marrow Cells in the Treatment of Insulin-Dependent Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating arterial delivery of autologous bone marrow cells for Type 1 diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Autologous bone marrow cell therapy (Autologous bone marrow cells)

Snippet

Sponsor: University of Moron | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: WITHDRAWN